A Double Blind (3rd Party Open), Randomized, Placebo Controlled, Crossover Study To Investigate The Effects Of Pf-06305591 On Cold Pain In Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 16 Sep 2013
At a glance
- Drugs PF 6305591 (Primary)
- Indications Pain
- Focus Pharmacodynamics
- 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Jul 2013 Planned end date changed from 1 Jun 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.
- 01 May 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.